Target Name: LOC105371800
NCBI ID: G105371800
Review Report on LOC105371800 Target / Biomarker Content of Review Report on LOC105371800 Target / Biomarker
LOC105371800
Other Name(s): LOC105371800 variant X2 | Uncharacterized LOC105371800, transcript variant X2 | uncharacterized LOC105371800

LOC105371800: A Potential Drug Target and Biomarker

LOC105371800 is a unique gene that has been identified as a potential drug target and biomarker. It is a non-coding RNA molecule that has been shown to play a critical role in the regulation of cellular processes, including cell adhesion, migration, and invasion. LOC105371800 has also been linked to various diseases, including cancer and neurodegenerative disorders.

The Discovery of LOC105371800

LOC105371800 was first identified using RNA sequencing (RNA-seq) technology. RNA-seq is a powerful tool that allows researchers to identify and quantify gene expression in a given sample. The LOC105371800 gene was identified by RNA-seq analysis of RNA samples from various organisms, including human, mouse, and plant cells.

Follow-up studies have further confirmed the validity of the LOC105371800 gene and its role in cellular processes. For instance, RNA-seq analysis has shown that LOC105371800 is highly expressed in various tissues and cells, including brain, pancreatic, and heart cells. Additionally, the gene has been shown to play a critical role in cell adhesion, migration, and invasion, as well as regulating the Wnt signaling pathway.

The Potential Importance of LOC105371800 as a Drug Target

LOC105371800 has been identified as a potential drug target due to its involvement in various cellular processes that are associated with various diseases, including cancer and neurodegenerative disorders. For instance, LOC105371800 has been shown to promote the growth and survival of cancer cells, which could make it an attractive target for anti-cancer drugs.

Additionally, LOC105371800 has been linked to various neurodegenerative disorders, including Alzheimer's and Parkinson's diseases. These disorders are characterized by the progressive loss of brain cells, which can lead to cognitive impairments and other debilitating symptoms. Therefore, LOC105371800 could be a promising target for neurodegenerative disorders.

The Potential Role of LOC105371800 as a Biomarker

LOC105371800 has also been shown to serve as a potential biomarker for various diseases, including cancer and neurodegenerative disorders. The expression of LOC105371800 has been shown to be associated with the progression of various diseases, including cancer and neurodegenerative disorders.

For instance, studies have shown that high expression of LOC105371800 is associated with poor prognosis in various cancer types, including breast, ovarian, and colorectal cancers. Additionally, the gene has been shown to be involved in the development and progression of neurodegenerative disorders, including Alzheimer's and Parkinson's diseases.

Conclusion

LOC105371800 is a unique gene that has been identified as a potential drug target and biomarker. Its role in the regulation of cellular processes and its association with various diseases make it an attractive target for research and development of new treatments. Further studies are needed to fully understand the potential of LOC105371800 as a drug target and biomarker.

Protein Name: Uncharacterized LOC105371800

The "LOC105371800 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105371800 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105371801 | LOC105371814 | LOC105371829 | LOC105371839 | LOC105371855 | LOC105371870 | LOC105371873 | LOC105371874 | LOC105371887 | LOC105371910 | LOC105371920 | LOC105371956 | LOC105371958 | LOC105371965 | LOC105371967 | LOC105371972 | LOC105372028 | LOC105372046 | LOC105372047 | LOC105372061 | LOC105372093 | LOC105372100 | LOC105372101 | LOC105372112 | LOC105372117 | LOC105372130 | LOC105372131 | LOC105372146 | LOC105372153 | LOC105372155 | LOC105372161 | LOC105372178 | LOC105372185 | LOC105372194 | LOC105372213 | LOC105372221 | LOC105372225 | LOC105372227 | LOC105372283 | LOC105372298 | LOC105372321 | LOC105372326 | LOC105372327 | LOC105372328 | LOC105372343 | LOC105372351 | LOC105372354 | LOC105372371 | LOC105372379 | LOC105372400 | LOC105372401 | LOC105372427 | LOC105372441 | LOC105372460 | LOC105372502 | LOC105372503 | LOC105372505 | LOC105372507 | LOC105372511 | LOC105372521 | LOC105372529 | LOC105372548 | LOC105372561 | LOC105372577 | LOC105372582 | LOC105372592 | LOC105372596 | LOC105372606 | LOC105372630 | LOC105372631 | LOC105372639 | LOC105372646 | LOC105372649 | LOC105372664 | LOC105372666 | LOC105372667 | LOC105372669 | LOC105372675 | LOC105372685 | LOC105372687 | LOC105372694 | LOC105372707 | LOC105372710 | LOC105372717 | LOC105372738 | LOC105372745 | LOC105372760 | LOC105372772 | LOC105372787 | LOC105372798 | LOC105372801 | LOC105372802 | LOC105372813 | LOC105372815 | LOC105372832 | LOC105372848 | LOC105372877 | LOC105372881 | LOC105372900 | LOC105372912